Pneumothorax occurs when air enters the pleural space, causing partial or complete lung collapse. Etiologies include spontaneous rupture of alveoli, trauma, or complications from medical procedures. Symptoms vary depending on severity and may range from mild chest discomfort and shortness of breath to sudden respiratory distress and hypotension. Prompt recognition is critical, as untreated cases can progress rapidly and become life-threatening. Diagnosis relies on chest imaging, including X-ray or computed tomography, to confirm the presence and size of the pneumothorax and assess underlying lung pathology.
Treatment strategies depend on the size, cause, and clinical stability of the patient. Small, asymptomatic pneumothoraces may resolve with observation and supplemental oxygen, while larger or symptomatic cases often require needle aspiration or chest tube insertion to evacuate air and allow lung re-expansion. Recurrent or persistent pneumothoraces may necessitate surgical intervention such as video-assisted thoracoscopic surgery (VATS) with pleurodesis. Post-treatment care emphasizes monitoring for recurrence, pulmonary rehabilitation, and patient education on lifestyle modifications, including avoiding high-pressure environments and smoking cessation. Advances in minimally invasive techniques and evidence-based management protocols have improved recovery rates and minimized complications, making pneumothorax treatment safer and more effective for a broad range of patients.
Title : Global warming and increasing respiratory illnesses
Yazdan Mirzanejad, University of British Columbia, Canada
Title :
Saurabh Chattopadhyay, University of Kentucky, United States
Title : Risk factors for mycobacterium avium complex infections in patients with chronic obstructive pulmonary disease
Alizaman Sadigov, Medical University, United States
Title : Managing integration and interoperability in transformed pulmonology, respiratory medicine and lung health ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Oncology (PPO) to be set up via precision oncology strategy for cancer care team: Developing targeted lung cancer therapy and advancing personalized cancer care
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Advancements in pulmonology and respiratory care through the view of Personalized and Precision Medicine (PPM) and biodesign-driven translational applications
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation